Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.
Authors: Li Y; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Thongborisuth T; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Lee R; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Stolberg N; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA., Sweiss N; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.; Discovery Partners Institute, University of Jordan, Amman, Jordan., Lobo-Chan AM; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Bhat P; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2025 Jun 24, pp. 1-9. Date of Electronic Publication: 2025 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-5078
DOI:10.1080/09273948.2025.2504577